Altered phosphate metabolism in HIV-1-infected patients with metabolic syndrome

References

• Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient Study investigators. N Engl J Med 1998;338:853–60.
   PubMed Web of Science ®Google Scholar
• Behrens G, Dejam A, Schmidt H, Balks HJ, Brabant G, Körner T, . Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS 1999;13:F63–70.
   PubMed Web of Science ®Google Scholar
• Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, . A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51–8.
   PubMed Web of Science ®Google Scholar
• Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000;356:1423–30.
   PubMed Web of Science ®Google Scholar
• Martinez E, Milinkovic A, Buira E, de Lazzari E, León A, Larrousse M, . Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med 2007;8: 251–8.
   PubMed Web of Science ®Google Scholar
• Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D, . Changes in causes of death among adults infected by HIV between 2000 and 2005: the “Mortalite 2000 and 2005” surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 2008;48:590–8.
   PubMed Web of Science ®Google Scholar
• Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, . Cardiovascular morbidity and mortality associated with metabolic syndrome. Diabetes Care 2001;24: 683–9.
   PubMed Web of Science ®Google Scholar
• Jerico C, Knobel H, Montero M, Ordoñez-Llanos J, Guelar A, Gimeno JL, . Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care 2005;28:132–7.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lefant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004;24:13–8.
   PubMed Web of Science ®Google Scholar
• Haglin L. Hypophosphatemia: cause of the disturbed metabolism in the metabolic syndrome. Med Hypotheses 2001;56: 657–63.
   PubMedGoogle Scholar
• Kalaitzidis R, Tsimihodimos V, Bairaktari E, Siamopoulos KC, Elisaf M. Disturbances of phosphate metabolism: another feature of metabolic syndrome. Am J Kidney Dis 2005;45:851–8.
   PubMed Web of Science ®Google Scholar
• Paula FJ, Plens AE, Foss MC. Effects of hypophosphatemia on glucose tolerance and insulin secretion. Horm Metab Res 1998;30:281–4.
   PubMedGoogle Scholar
• Walton RJ, Bijvoet OL. Normogram for derivation of renal threshold phosphate concentration. Lancet 1975;2:309–10.
   PubMed Web of Science ®Google Scholar
• Walton RJ, Bijvoet OL. A simple slide-rule method for the assessment of renal tubular reabsorption of phosphate in man. Clin Chim Acta 1977;81:273–6.
   PubMed Web of Science ®Google Scholar
• Worm SA, Friis-Møller N, Bruyand M, D'Arminio Monforte A, Rickenbach M, Reiss P, . High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome. AIDS 2010;24: 427–35.
   PubMed Web of Science ®Google Scholar
• Bagnis CI, Karie S, Deray G, Essig M. Hypophosphataemia: an easy strategy for diagnosis and treatment in HIV patients. Antivir Ther 2009;14:481–8.
   PubMedGoogle Scholar
• Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 2004;18:541–6.
   PubMed Web of Science ®Google Scholar
• Karras A, Lafaurie M, Furco A, Bourgarit A, Droz D, Sereni D, . Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. Clin Infect Dis 2003;36:1070–3.
   PubMed Web of Science ®Google Scholar
• Creput C, Gonzales-Canali G, Hill G, Piketty C, Kazatchkine M, Nochy D. Renal lesions in HIV-1-positive patient treated with tenofovir. AIDS 2003;17:2543–4.
   PubMedGoogle Scholar
• Cooper RD, Wiebe N, Smith N, Keiser P, Naicker S, Tonelli M. Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV infected patients. Clin Infect Dis 2010;51:496–505.
   PubMed Web of Science ®Google Scholar
• Mallon PW. HIV and bone mineral density. Curr Opin Infect Dis 2010;23:1–8.
   PubMedGoogle Scholar
• Riley MS, Schade DS, Eaton RP. Effects of insulin infusion on plasma phosphate in diabetic patients. Metabolism 1979;28:191–4.
   PubMedGoogle Scholar
• Bohannon NJ. Large phosphate shift with treatment for hyperglycemia. Arch Intern Med 1989;149:1423–5.
   PubMedGoogle Scholar
• Ritz E, Kreusser W, Bommer J. Effects of hormones other than parathyroid hormone on renal handling of phosphate. In: Massry SG, Fleisch H, editors. Renal handling of phosphate. Plenum Medical Book Co; 1980 pp 137–95.
   Google Scholar
• Weisinger JR, Bellorin-Font E. Magnesium and phosphorus. Lancet 1998;352:391.
   PubMed Web of Science ®Google Scholar
• Marshall WP, Banasiak MF, Kalkhoff RK. Effects of phosphate deprivation on carbohydrate metabolism. Horm Metab Res 1978;10:369–73.
   PubMedGoogle Scholar
• Davis JL, Lewis SB, Schultz TA, Kaplan RA, Wallin JD. Acute and chronic phosphate depletion as a modulator of glucose uptake in rat skeletal muscle. Life Sci 1979;24:629–32.
   PubMedGoogle Scholar